ORIGINAL PAPER / GYNECOLOGY

Ginekologia Polska

2022, vol. 93, no. 12, 962–967

Copyright © 2022 PTGiP

ISSN 0017–0011, e-ISSN 2543–6767

DOI 10.5603/GP.a2022.0019

Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins

Yagmur Minareci1Naziye Ak2Ozgur Aydın Tosun3Hamdullah Sozen4Rian Disci5Samet Topuz4Mehmet Yavuz Salihoglu4
1Eskisehir City Hospital, Department of Gynecologic Oncology, Eskisehir, Turkey
2Istanbul University, Institute of Oncology, Department of Medical Oncology, Istanbul, Turkey
3Istanbul Medeniyet University, Goztepe Research and Training Hospital, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Istanbul, Turkey
4Istanbul University, Faculty of Medicine, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Istanbul, Turkey
5Beykent University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Istanbul, Turkey
ABSTRACT
Objectives: No consensus exists on the subsequent management strategy of patients who exhibit positive surgical margin (PSM) after re-excision of high-grade cervical intraepithelial neoplasia (CIN). The aim of the study is to examine the predictors related to the persistence of high-grade CIN lesions after re-excision, where PSM was left behind.
Material and methods: The present retrospective study included patients with PSM who underwent repeated conization due to residual high-grade CIN lesions between January 2005 and December 2019. The SPSS software v20.0 was used for data interpretation and statistical analysis. P values less than 0.05 were accepted as statistically significant.
Results: Repeat conization was performed in 91 patients, 43 (47.3%) presented with PSM with high-grade CIN, 6 (6.5%) presented with micro-invasive carcinoma, and 42 (46.2%) presented with clear surgical margin or CIN 1 at the surgical margin. At the time of conization, patients who presented with lesions > 5 mm in repeat cone specimens, exhibited a significantly higher rate of residual disease (p < 0.001). Besides, the involvement of the endocervical margin with high-grade CIN was the predictor of residual disease in repeat cone specimens (p = 0.006).
Conclusions: In the cone specimen, the presence of lesion size greater than 5 mm and involvement of the endocervical margin were the predictors of high-grade residual disease after re-excision. Whether it is the first or second procedure, great care must be given to excise the lesion entirely at the time of the conization, preferably in one piece.
Key words: cancer of the cervix; cytology and GYN pathology; HPV infection and CIN
Ginekologia Polska 2022; 93, 12: 962967

Corresponding author:

Yagmur Minareci

Eskisehir Şehir Hastanesi, B blok, 1. Kat, Jinekolojik Onkoloji Polikliniği, 71. Evler mah, 26080 Odunpazarı, Eskişehir, Turkey

e-mail: dryagmurminareci@gmail.com

tel.: +90 505 357 4361

Received: 14.09.2021 Accepted: 09.03.2022 Early publication date: 23.05.2022

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download

articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

INTRODUCTION

The treatment for pre-invasive neoplastic lesions aims to prevent invasive cervical cancer development. Conization is accepted as the first-line treatment modality of patients with high-grade cervical intraepithelial neoplasia (CIN) and may be performed by cold-knife excision or loop electrosurgical excision procedure (LEEP) [1]. However, in some cases, high-grade CIN lesions cannot be completely excised at the time of conization, exposing the patient to an increased risk of developing cervical cancer [2]. Researchers reported that 5% to 25% of cases after conization may exhibit surgical margin positivity, which is characterized by high-grade CIN lesions [3]. Thus, in a meta-analysis that including 35,109 cases, patients with clear surgical margins exhibited a prevalence of high-grade CIN lesions of 3% vs 18% compared to patients with positive or uncertain surgical margins, after the conization procedure [4]. The subsequent treatment strategy of patients with positive surgical margins (PSM) is still controversial. According to the 2019 guideline of the American Society for Colposcopy and Cervical Pathology (ASCCP), re-excision to achieve clear surgical margin should be the preferred next step [5]. However, re-excision procedure reduces the amount of cervical stroma and may cause obstetric complications in further pregnancies [6].

Moreover, no consensus exists on the subsequent management strategy of patients who present with PSM after re-excision of high-grade CIN [7]. In the present study, we aimed to examine the predictors related to the persistence of high-grade CIN lesions after re-excision, where PSM was left behind.

MATERIAL AND METHODS

The patients who underwent repeated conization due to residual high-grade CIN lesions between January 2005 and December 2019 at the Istanbul University, Faculty of Medicine, Department of Gynecological Oncology were retrospectively evaluated. The inclusion criterion was the presence of a pathological diagnosis of positive surgical margin containing CIN2 in re-excision specimen. Exclusion criteria were (a) presence of a pathological diagnosis of clear surgical margin in re-excision specimen, (b) presence of a pathological diagnosis of surgical margin containing CIN 1 lesion or invasive cancer in re-excision specimen, and (c) presence of missing data in hospital records while meeting the inclusion criterion. High-grade CIN lesions were considered CIN 2 and CIN 3. Re-excision procedure was performed by a gynecologic oncologist using either LEEP or cold knife.

The primary endpoint of the present study was to evaluate the correlations between the margin positivity after repeat conization with the following variables: age, parity, cytology result, menopausal status, conization technique (LEEP vs cold knife), endocervical curettage (ECC) result, cone volume, cone depth, largest lesion diameter, number of passes, and final pathological reports of first and repeat cone specimens. Iodine solution was used to mark the limits of the lesion before the conization. ECC was performed to evaluate the endocervical canal. LEEP was performed by a 1520 mm loop electrode in a single pass when possible, and in the presence of large lesions, multiple passes were performed. PSM, either ectocervical or endocervical, was defined as the presence of high-grade CIN at the edge of the cone specimen in the final pathological evaluation. Following the diagnosis of PSM, in order to avoid treatment delay and to reduce the patient anxiety, patients underwent repeat conization within six weeks after the first conization. Cone volume was calculated with the formula = depth × width × length × π/3 × 1/4. The diameters of the cone specimens were obtained from the pathological report. Written informed consent was obtained from all the patients before surgery. The institutional review board and ethics committee approved our study protocol (ethics number: 1403, date: 2019), and they waived the requirement to obtain informed consent for study due to retrospective nature.

The SPSS software v20.0 was used for data interpretation and statistical analysis. Continuous variables have been shown in median with range, and they have been categorized based on median value to run appropriate statistical analyses. Categorical variables were compared with Fisher’s exact test or chi-square test. A logistic regression model was used to measure association of variables for multivariate analysis. P values less than 0.05 were accepted as statistically significant.

RESULTS

We identified 114 patients who exhibited surgical margin positivity with high-grade CIN after first conization from the hospital records. Of the 114 patients, 23 (20.2%) underwent reflex extrafascial hysterectomy, and 91 (79.8%) exhibited repeat conization. At the time of repeat conization, among the 91 patients, 43 (47.3%) exhibited high-grade CIN lesion at the surgical margin, 42 exhibited (46.2%) clear surgical margin or CIN 1 lesion at the surgical margin, and 6 (6.5%) exhibited micro-invasive cancer. The clinicopathological features of 43 patients with PSM are detailed in Table 1. Among the 43 patients, 26 (60.5%) were smokers, 33 (76.7%) were at least primiparous, 10 (23.3%) were nulliparous. Median age was 35 years (range 2955), median follow-up period was 31.1 months (range 7156), median depth of cone specimen was 12 mm (range 1020), and median diameter of lesion was 5 mm (range 113 mm). Leep and cold knife conization were performed in 39 (90.7%) and 4 (9.3%) women, respectively. Of the 39 patients with PSM who underwent LEEP conization, 18 exhibited CIN 3, and 21 exhibited CIN 2; of the four patients who had cold knife conization, 1 exhibited CIN 3, and 3 exhibited CIN 2 lesion. On the other hand, of the 42 patients with CIN1, LEEP and cold knife conization were performed in 37 and 5, respectively. Of the 37 patients who underwent LEEP conization, 17 exhibited CIN 1; of the 5 patients who had cold knife conization, 4 exhibited CIN 1 lesion. Among the patients who exhibited leep conization, 37 (86%) required a single pass, and 6 (14%) required double passes. In addition, the clinical and demographic parameters of the patients (n = 43) with CIN2 lesions at the surgical margin after repeat conization and those (n = 42) with CIN1 were shown in Table 2. The most striking results to emerge from our data are stated under 2 main items: (a) the patients who presented with lesions > 5 mm in repeat cone specimens exhibited a significantly higher rate of residual disease (p < 0.001), and (b) in repeat cone specimens, the involvement of the endocervical margin with high-grade CIN was significantly higher in patients who presented with residual disease (p = 0.006). Severity of disease (CIN 2 vs CIN 3),ECC result, largest cone diameter, cone volume, and cone depth did not predict residual disease after repeat conization. In multivariate analysis, the risk of residual disease was increased in patients who presented with lesion > 5 mm (p < 0.001) and even higher in patients with endocervical margin involvement (p < 0.001). No other variables were significantly associated with residual disease. Table 3 shows the relationship of the pathological reports between the first and repeat conization procedure.

Table 1. Clinicopathological parameters of 43 patients with positive surgical margin after repeat conization

Characteristic

Values

Age, years, median (range)

35 (2955)

Parity, n (%)

Nullipara

Primipara

Multipara

10 (23.3)

15 (34.9)

18 (41.8)

Smoking status, n (%)

Yes

No

17 (39.5)

26 (60.5)

Menopausal status, n (%)

Premenapousal

Postmenapousal

39 (90.6)

4 (9.4)

Referral cytology result, n (%)

ASCUS

LSIL

ASCH

HSIL

7 (16.3)

15 (34.9)

6 (13.9)

15 (34.9)

Colposopic biyopsy result, n (%)

CIN 2

CIN 3

6 (14.0)

37 (86.0)

First conization result, n (%)

CIN 2

CIN 3

11 (25.6)

32 (74.4)

ECC, n (%)

Positive

Negative

15 (34.9)

28 (65.1)

Endocervical margin involvement

Positive

Negative

25 (58.1)

18 (41.9)

Number of passes, n (%)

1

> 1

37 (86.0)

6 (14.0)

Conization technique, n (%)

LEEP

Cold knife

39 (90.7)

4 (9.3)

Cone volume, cm3, median (range)

13.5 (10.352.9)

Cone depth, mm, median (range)

12 (1020)

Lenght of lesion, mm, median (range)

5 (113)

Followup period, months, median (range)

31.1 (7156)

PSM positive surgical margin; LEEP loop electrosurgical excision procedure; ASC-US atypical squamous cells of undetermined significance; LSIL low-grade squamous intraepitehial lesion; ASC-H atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion; HSIL high-grade squamous intraepitehial lesion; CIN cervical intraepithelial neoplasia; ECC endocervical curettage

Table 2. Comparison of the patient parameters with cervical intraepithelial neoplasia (CIN)2 lesions at the surgical margin after repeat conization and those with CIN1

Parameter

With margin positivity

n = 43

Without margin positivity

n = 42

p value

Age [years]

< 35

≥ 35

16 (37.2%)

27 (62.8%)

12 (28.6%)

30 (71.4%)

0.39

Smoking status

Yes

No

17 (39.5%)

26 (60.5%)

21 (50.0%)

21 (50.0%)

0.33

Parity

<1

≥1

10 (23.3%)

33 (76.7%)

7 (16.7%)

35 (81.3%)

0.17

Menopausal status

Premenopause

Postmenopause

4 (9.3%)

39 (90.7%)

3 (7.1%)

39 (92.9%)

0.72

Referral cytology result

ASC-US & LSIL

ASC-H & HSIL

22 (51.2%)

21 (48.8%)

18 (42.9%)

24 (57.1%)

0.59

Colposcopic biopsy result

CIN 2

CIN 3

6 (14.0%)

37 (86.0%)

8 (19.0%)

34 (81.0%)

0.53

First conization result

CIN 2

CIN 3

11 (25.6%)

32 (74.4%)

14 (33.3%)

28 (66.7%)

0.55

Re-excision method

LEEP

Cold Knife

39 (90.7%)

4 (9.3%)

37 (88.1%)

5 (11.9%)

0.72

Endocervical margin involvement

Positive

Negative

25 (58.1%)

18 (41.9%)

12 (28.6%)

30 (71.4%)

0.006

ECC

Positive

Negative

15 (34.9%)

28 (65.1%)

16 (38.1%)

26 (61.9%)

0.76

Lenght of lesion [mm]

< 5

≥ 5

18 (41.9%)

25 (58.1%)

39 (92.9%)

3 (7.1%)

< 0.001

Cone volume [cm3]

< 13.5

≥ 13.5

18 (41.9%)

25 (58.1%)

15 (35.7%)

27 (64.3%)

0.56

Cone depth [mm]

< ١٢

≥ 12

17 (39.5%)

26 (60.5%)

14 (33.3%)

28 (66.7%)

0.42

LEEP loop electrosurgical excision procedure; ASC-US atypical squamous cells of undetermined significance; LSIL Low-grade squamous intraepitehial lesion; ASC-H atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion; HSIL high-grade squamous intraepitehial lesion; CIN cervical intraepithelial neoplasia; ECC endocervical curettage

Table 3. The relationship of the pathological reports between the first and repeat conization procedure (n = 91)

First conization pathology

Repeat conization pathology

≤ CIN 1

CIN 2

CIN 3

Micro-invasive

Invasive

Total

CIN 2

14

9

2

0

0

25

CIN 3

28

15

17

6

0

66

Total

42

24

19

6

0

91

One patient was diagnosed with invasive cancer after pathological evaluation of hysterectomy specimen; CIN cervical intraepithelial neoplasia

In the subgroup analysis, of the 23 patients who underwent reflex extrafascial hysterectomy due to PSM after the first conization, 2 (8.7%) presented with invasive cervical cancer (stage 1B1) and underwent radical parametrectomy, upper vaginectomy, and lymph node dissection. The decision of reflex hysterectomy was mainly due to the gynecologic co-morbidity, including the presence of ovarian cystic lesion, uterine fibroid, endometrial hyperplasia, intractable menorrhagia, etc. Conversely, of the 91 patients who presented with repeat conization, 6 (6.5%) were diagnosed with micro-invasive cancer (stage 1A1) and underwent extrafascial hysterectomy. Interestingly, 1 of them received the final pathological diagnosis of invasive cancer (stage 1B1). Accordingly, this patient also underwent radical parametrectomy, upper vaginectomy, and lymph node dissection. The remaining 5 who presented with no residual disease in the hysterectomy specimen were followed up closely. Among the 43 patients with PMS after repeat conization, 12 (27.9%) underwent extrafascial hysterectomy directly, 4 (9.3%) underwent the third conization, and 1 out of 4 patients underwent the fourth conization using a cold knife one year after the third conization due to the presence of CIN 3 in biopsy specimen. Unfortunately, it was complicated by posterior fornix perforation and resulted in entry to the pelvic cavity. Therefore, diagnostic laparoscopy was performed. None of them received the final pathologic diagnosis of invasive cancer. Finally, for 27 of 43 patients (62.8%), no further intervention was performed, and they followed up with cytology and colposcopic evaluation (Fig. 1). In principle, repeat (third) conization was recommended to all 43 patients. However, the treatment choice was given primarily considering the fertility desire and age. Hysterectomy was preferred in patients who were in perimenopause and rejected the third conization procedure. On the other hand, young patients with fertility desire were followed up closely without intervention to preserve cervical stroma.

Figure 1. Flow Diagram of the study; PSM positive surgical margin; CIN cervical intraepithelial neoplasia

DISCUSSION

In the present study, we found that the presence of lesions greater than 5 mm and involvement of endocervical margins were the predictors of high-grade residual lesions in cone specimens after repeat conization. To our knowledge, this is the first study to investigate the predictors of residual disease in patients who received the re-excision procedure due to persistent surgical margin positivity. Our results may provide a prognostic tool for predicting which women with residual disease after repeat conization could be managed with a conservative strategy and which might require an aggressive treatment strategy.

Previous studies revealed that CIN 3 lesions tend to be confluent and are more likely to be solitary rather than multifocal in distribution, also they have shown that the larger CIN 3 lesions may exhibit a higher risk of progression to cancer [8]. In addition, previous reports revealed that the large CIN lesions were associated with a higher rate of post conization residual disease. Chen et al. [9] published a retrospective analysis of 1,113 patients who underwent conization due to CIN 3 and examined the predictors of residual disease in 141 patients with PSM. They finally concluded that lesions greater than two-thirds of the cervix at visual inspection presented with a higher rate of surgical margin positivity (relative risk 1.3; 95% CI, 1.12.3). Similarly, Shaco-Levy et al. [10] retrospectively analyzed 376 women who presented with conization due to high-grade CIN to identify the predictors associated with PSM. The authors concluded that patients with extensive lesions demonstrated an increased risk of persistent/recurrent disease compared to patients with focal lesions in cone specimens (hazard ratio = 27.6; 95% CI, 8.985.5). Recently, Diaz et al. [11] evaluated the predictors of residual lesions comprised of carcinoma or high-grade CIN at hysterectomy specimens following conization procedure due to PSM or positive ECC or micro-invasive carcinoma. They reported that the presence of the disease in50% of the total cone volume at the pathological evaluation was a predictor of residual disease (26% for < 50% vs 44% for50%, p < 0.01). However, the results of all these studies were limited to patients who underwent the first conization procedure and did not address the risk of residual disease in patients who had repeat conization. In the present study, our results revealed that lesions > 5 mm in the cone specimen after repeat conization were significantly associated with persistent residual disease.

Conversely, the results of the present study were similar to those of other studies that stated that the involvement of endocervical margin was the predictor of residual disease. Roman et al. [12] stated that endocervical margin positivity was a significant predictor of post conization residual disease (22% with positive margin vs 3% without positive margin, p < 0.03). More recently, Park et al. [13] found that the presence of positive endocervical margin after conization was an independent predictor of residual disease. However, the studies mentioned above made these conclusions on the data obtained after the first conization. Finally, these authors highlighted that in the presence of positive endocervical margin after the conization procedure, repeat conization should be performed before definitive treatment. In our limited cohort, 2 patients with residual CIN2 lesion after the first conization and 1 patient with micro-invasive carcinoma after the repeat conization presented with the diagnosis of invasive carcinoma in hysterectomy specimens. However, in these circumstances, repeat conization might be preventive for malpractice and exceptional surgical interventions including radical parametrectomy and upper vaginectomy [14]. Like the recommendations made by these authors, we strongly suggest repeat conization before hysterectomy in patients with PSM, particularly with endocervical margin involvement. However, our recommendation for repeat conization is a step that should be administered only in patients who are scheduled for hysterectomy. Patients who demonstrate fertility desire with PSM after initial conization should be managed according to the recommendations of ASCCP [5].

Interestingly, although only six patients demonstrated double passes during the repeat conization procedure, high-grade residual disease was found at the surgical margins in five specimens on pathological evaluation. Besides, all the lesions were reported as CIN 3 in cone specimens. Recent publications on the subject emphasized that multiple passes were significantly associated with the residual disease during the first conization procedure [15–17]. However, a small number of patients was found who demonstrated multiple passes in our study. Therefore, drawing a definitive conclusion was insufficient.

The present study exhibits some limitations. First, due to its retrospective nature, undetected bias might occur. Second, the limited number of patients in the study cohort is another disadvantage. Third, our clinical tendency to use LEEP more than cold knife for repeat conization to avoid complications of cold-knife excision might be a limitation of this study. Finally, the relationship between human papillomavirus types and residual disease after repeat conization has not been evaluated. Conversely, a key strength of the present study is its design, in which we principally investigate the patients with persistent high-grade disease after repeat conization.

CONCLUSIONS

In conclusion, the present study revealed two predictors that were statistically associated with PSM after re-excision procedure. Accordingly, in re-excision specimens, the presence of lesions greater than 5 mm and the involvement of endocervical margin were the predictors of high-grade residual disease. We concluded that repeat conization should be preferred instead of reflex hysterectomy in patients with PSM after the first conization. Finally, whether it is first or repeat, great care must be given to excise the lesion entirely at the time of the conization procedure, preferably in one piece.

Disclosure

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author contributions

Conceptualization, Methodology: Y. Minareci, H. Sozen, M.Y. Salihoglu, S. Topuz.

Software, Validation, Data Curation, Formal Analysis: Y. Minareci, N. Ak, O.A. Tosun.

Writing original draft: Y. Minareci, H. Sozen, N. Ak, O.A. Tosun.

Writing review & editing: Y. Minareci, H. Sozen, N. Ak, O.A. Tosun, M.Y. Salihoglu, S. Topuz.

Visualization, Supervision, Project Administration, Investigation, Resources: Y. Minareci, H. Sozen, N. Ak, O.A. Tosun, M.Y. Salihoglu, S. Topuz.

Statistical analysis: R. Disci

Conflict of interest

All authors declare no conflict of interest.

References

  1. Sun X, Lei H, Xie X, et al. Risk Factors for Residual Disease in Hysterectomy Specimens After Conization in Post-Menopausal Patients with Cervical Intraepithelial Neoplasia Grade 3. Int J Gen Med. 2020; 13: 10671074, doi: 10.2147/IJGM.S280576, indexed in Pubmed: 33204141.
  2. Serati M, Siesto G, Carollo S, et al. Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study. Eur J Obstet Gynecol Reprod Biol. 2012; 165(1): 8690, doi: 10.1016/j.ejogrb.2012.06.026, indexed in Pubmed: 22771223.
  3. Zhang H, Zhang T, You Z, et al. Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization. PLoS One. 2015; 10(12): e0142868, doi: 10.1371/journal.pone.0142868, indexed in Pubmed: 26624896.
  4. Ghaem-Maghami S, Sagi S, Majeed G, et al. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol. 2007; 8(11): 985993, doi: 10.1016/S1470-2045(07)70283-8, indexed in Pubmed: 17928267.
  5. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines Committee, 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2): 102131, doi: 10.1097/LGT.0000000000000525, indexed in Pubmed: 32243307.
  6. Kyrgiou M, Athanasiou A, Paraskevaidi M, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016; 354: i3633, doi: 10.1136/bmj.i3633, indexed in Pubmed: 27469988.
  7. Tasci T, Turan T, Ureyen I, et al. Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer? J Low Genit Tract Dis. 2015; 19(2): 115118, doi: 10.1097/LGT.0000000000000079, indexed in Pubmed: 25259663.
  8. Ferris DG, Cox JT, Mayeaux EJ. Colposcopy of cervical intraepithelial neoplasia. In: Mayeaux EJ, Cox JT. ed. Modern Colposcopy Textbook & Atlas, Third edition. Lippincott Williams & Wilkins 2012: 234305.
  9. Chen Y, Lu H, Wan X, et al. Factors associated with positive margins in patients with cervical intraepithelial neoplasia grade 3 and postconization management. Int J Gynaecol Obstet. 2009; 107(2): 107110, doi: 10.1016/j.ijgo.2009.05.027, indexed in Pubmed: 19628208.
  10. Shaco-Levy R, Eger G, Dreiher J, et al. Positive margin status in uterine cervix cone specimens is associated with persistent/recurrent high-grade dysplasia. Int J Gynecol Pathol. 2014; 33(1): 8388, doi: 10.1097/PGP.0b013e3182763158, indexed in Pubmed: 24300540.
  11. Diaz ES, Aoyama C, Baquing MA, et al. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins. Gynecol Oncol. 2014; 132(1): 7680, doi: 10.1016/j.ygyno.2013.11.019, indexed in Pubmed: 24262876.
  12. ROMAN L, FELIX J, MUDERSPACH L, et al. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstetrics & Gynecology. 1997; 90(5): 759764, doi: 10.1016/s0029-7844(97)00414-6.
  13. Park JY, Lee SMi, Yoo CW, et al. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Gynecol Oncol. 2007; 107(1): 3944, doi: 10.1016/j.ygyno.2007.05.014, indexed in Pubmed: 17582476.
  14. Ayhan A, Boynukalin FK, Guven S, et al. Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins. Int J Gynaecol Obstet. 2009; 105(1): 1417, doi: 10.1016/j.ijgo.2008.11.015, indexed in Pubmed: 19111301.
  15. Ayhan A, Tuncer HA, Reyhan NH, et al. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins. Eur J Obstet Gynecol Reprod Biol. 2016; 201: 16, doi: 10.1016/j.ejogrb.2016.03.021, indexed in Pubmed: 27038228.
  16. Demirkiran F. Management of positive resection margin after treatment for cervical precancer, Chapter 40. In: Ayhan A, Reed N, Gultekin M, Dursun P. ed. Textbook of Gynaecological Oncology, Third Edition. Gunes tip kitabevi 2015: 372375.
  17. Papoutsis D, Rodolakis A, Mesogitis S, et al. Appropriate cone dimensions to achieve negative excision margins after large loop excision of transformation zone in the uterine cervix for cervical intraepithelial neoplasia. Gynecol Obstet Invest. 2013; 75(3): 163168, doi: 10.1159/000345864, indexed in Pubmed: 23296191.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl